Skip to main content

Country Hub

  • Country portal

Secondary nav

  • Gavi's next strategic period
  • #ForOurFuture
  • Ethics Hotline
  • English
  • Français
Home

Main navigation

  • Our Alliance
    About
    • Mission & vision
    • Our impact
    • Leadership
    Strategy
    • Current (2021–2025)
    • Next (2026–2030)
    • Vaccine Investment Strategy 2024
    • Risk management
    • Learning System Strategy
    • Gender & immunisation
    • Climate, health & immunisation
    Operating model
    • Our partners
    • Business model
    • People & leadership
    • Data & transparency
    Governance
    • Gavi Board
    • Governance & legal structures
    • Board & Committee minutes
    • Corporate Policies
    • Audit & investigations
    Market Shaping
    • Vaccine Innovation Prioritisation Strategy (VIPS)
    • Vaccine demand forecasting
    • Roadmaps
    • Product information: vaccines & cold chain equipment
    Global health & development
    • Sustainable Development Goals
    • International Health Partnership for UHC 2030
    • Decade of Vaccines Collaboration
    • Millennium Development Goals
    Work with us
    • Vacancies
    • Internships
    • RFPs & consulting opportunities

    Contact us ISO certification Phishing & fraud

    • About
      • Mission & vision
      • Our impact
      • Leadership
    • Strategy
      • Current (2021–2025)
      • Next (2026–2030)
      • Vaccine Investment Strategy 2024
      • Risk management
      • Learning System Strategy
      • Gender & immunisation
      • Climate, health & immunisation
    • Operating model
      • Our partners
      • Business model
      • People & leadership
      • Data & transparency
    • Governance
      • Gavi Board
      • Governance & legal structures
      • Board & Committee minutes
      • Corporate Policies
      • Audit & investigations
    • Market Shaping
      • Vaccine Innovation Prioritisation Strategy (VIPS)
      • Vaccine demand forecasting
      • Roadmaps
      • Product information: vaccines & cold chain equipment
    • Global health & development
      • Sustainable Development Goals
      • International Health Partnership for UHC 2030
      • Decade of Vaccines Collaboration
      • Millennium Development Goals
    • Work with us
      • Vacancies
      • Internships
      • RFPs & consulting opportunities

    Contact us ISO certification Phishing & fraud

  • Programmes & Impact
    How our support works
    • Support guidelines
    • Independent Review Committee
    • Joint appraisals
    • Country portal
    Programmatic support
    • Vaccine support
    • Funding for civil society organisations (CSOs)
    • Health systems & immunisation strengthening
    • Partners' Engagement Framework (PEF)
    • Global health security
    Regional manufacturing strategy
    • Overview
    • African Vaccine Manufacturing Accelerator (AVMA)
    • Vaccine market dashboard
    Country Hub
    • All countries
    • Africa
    • Americas
    • Eastern Mediterranean
    • Europe
    • South-East Asia
    • Western Pacific
    Our impact
    • Progress reports
    • Facts & figures
    • Digital health information (DHI)
    • Measuring our performance
    • Evaluation studies
    Programmatic policies
    • Eligibility & co-financing policies
    • Fragility, emergencies & displaced populations policy
    • Gender policy
    • Health systems & immunisation strengthening policy
    • Prioritisation mechanism
    • Risk policy
    • Self-procurement policy
    • Transparency & accountability
    • Vaccine donation policy

    About Gavi Facts & figures Contact us

    • How our support works
      • Support guidelines
      • Independent Review Committee
      • Joint appraisals
      • Country portal
    • Programmatic support
      • Vaccine support
      • Funding for civil society organisations (CSOs)
      • Health systems & immunisation strengthening
      • Partners' Engagement Framework (PEF)
      • Global health security
    • Regional manufacturing strategy
      • Overview
      • African Vaccine Manufacturing Accelerator (AVMA)
      • Vaccine market dashboard
    • Country Hub
      • All countries
      • Africa
      • Americas
      • Eastern Mediterranean
      • Europe
      • South-East Asia
      • Western Pacific
    • Our impact
      • Progress reports
      • Facts & figures
      • Digital health information (DHI)
      • Measuring our performance
      • Evaluation studies
    • Programmatic policies
      • Eligibility & co-financing policies
      • Fragility, emergencies & displaced populations policy
      • Gender policy
      • Health systems & immunisation strengthening policy
      • Prioritisation mechanism
      • Risk policy
      • Self-procurement policy
      • Transparency & accountability
      • Vaccine donation policy

    About Gavi Facts & figures Contact us

  • Investing in Gavi
    Resource mobilisation
    • Global Summit: Health & Prosperity through Immunisation
    • Process
    Funding
    • Overview 2000–2037
    Our donors
    • Donor governments and the European Union
    • Foundations, corporations, institutions and organisations
    Partnering with business
    • Partnership types
    • Why partner with Gavi
    Innovative financing
    • International Finance Facility for Immunisation (IFFIm)
    • Pneumococcal Advance Market Commitment (AMC)
    • Gavi Matching Fund
    • Loan buydown
    INFUSE
    • INFUSE community
    • Call for innovations

    Strategic finance

    Innovative financing

    As part of our long-term funding and private sector engagement strategy, we use innovative finance mechanisms to incentivise investment in immunisation.

    Learn more

    Key publication

    IO


    Gavi's Investment Opportunity 
    2026–2030

    Download

    Global Summit, 25 June 2025

    • Resource mobilisation
      • Global Summit: Health & Prosperity through Immunisation
      • Process
    • Funding
      • Overview 2000–2037
    • Our donors
      • Donor governments and the European Union
      • Foundations, corporations, institutions and organisations
    • Partnering with business
      • Partnership types
      • Why partner with Gavi
    • Innovative financing
      • International Finance Facility for Immunisation (IFFIm)
      • Pneumococcal Advance Market Commitment (AMC)
      • Gavi Matching Fund
      • Loan buydown
    • INFUSE
      • INFUSE community
      • Call for innovations

    Global Summit, 25 June 2025

  • VaccinesWork
    Topics
    • Stories from the community
    • Emerging threats
    • News from the lab
    • Tales from the past
    • Vaccine profiles
    • Gavi matters
    VaccinesWork

     

    VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.

    About | Homepage

    Dr. Sania Nishtar, CEO of Gavi, the Vaccine Alliance, visited Ghana to observe the country’s pioneering efforts in integrating biometric technology into healthcare delivery. Credit: Simprints
    Gavi CEO, Dr. Sania Nishtar visits Ghana to support biometric innovation in healthcare 20 May 2025
    Panoramic view to the lower belt of Wabane, Southwest Region of Cameroon. Credit: Commons Wikimedia
    Faith-based organisation bridges immunisation gap in conflict-affected regions of Cameroon 20 May 2025
    Zimmerman Community members at a market. Credit: Gitonga.
    The unseen shield: community health workers on Kenya’s immunisation frontier 19 May 2025

    Latest VaccinesWork About VaccinesWork Contact the Editor

    • Topics
      • Stories from the community
      • Emerging threats
      • News from the lab
      • Tales from the past
      • Vaccine profiles
      • Gavi matters

    Latest VaccinesWork About VaccinesWork Contact the Editor

  • News & resources
    Media room
    • News releases
    • Media contacts
    • Media resources
    Resources
    • Knowledge products
    • Communication toolkits
    • Leadership biographies
    • Progress reports
    • Publications
    Document library
    • Board & Committee minutes
    • Evaluations
    • Independent Review Committee (IRC) reports
    • Financial reports

    Latest insights

    Polio vaccinators. Credit: UNICEF/ACQUAH

    How we fight disease outbreaks: first-hand accounts from the epidemic frontlines

    Learn more

    News releases

    Gavi news releases


    View all our news releases to read the latest announcements

    View news releases

    About Gavi Facts & figures Contact us

    • Media room
      • News releases
      • Media contacts
      • Media resources
    • Resources
      • Knowledge products
      • Communication toolkits
      • Leadership biographies
      • Progress reports
      • Publications
    • Document library
      • Board & Committee minutes
      • Evaluations
      • Independent Review Committee (IRC) reports
      • Financial reports

    About Gavi Facts & figures Contact us

    • Country portal
    • Gavi's next strategic period
    • #ForOurFuture
    • Ethics Hotline
    • English
    • Français

  • English
  • Français
  • Home
  • VaccinesWork
  • Could COVID-19 be fuelling drug resistance?
Credit: Biplov Bhuyan/Hindustan Times via Getty Images – A worker cleans the exterior of a train coach that has been converted into a Covid-19 isolation ward in New Delhi, India. Healthcare systems have had to rapidly adapt infection control practices to isolate coronavirus patients.
Back to

Could COVID-19 be fuelling drug resistance?

We need to understand the impact of Covid-19 on wider health issues to shape better public health responses and limit long-term consequences. Drug resistance is one of these, Gemma Buckland-Merrett explains.

22 September 2020 – originally published on 16 September 2020 by Wellcome

Back to

Could COVID-19 be fuelling drug resistance?

We need to understand the impact of Covid-19 on wider health issues to shape better public health responses and limit long-term consequences. Drug resistance is one of these, Gemma Buckland-Merrett explains.

22 September 2020 – originally published on 16 September 2020 by Wellcome

COVID-19Antimicrobial resistanceCross-posts
  • by Wellcome
    • Home

    Footer

    • Our Alliance
    • Programmes & impact
    • Investing in Gavi
    • VaccinesWork
    • News & resources

    Country Hub

    • Country portal

    Donate

    • #ForOurFuture
    • Donate

    Footer nav

    • Careers
    • Contact
    • Ethics hotline
    • IFFIm
    • Privacy notice
    • Terms of use
    • Phishing and fraud

    © Gavi 2025

    • Gavi LinkedIn
    • Gavi Twitter
    • Gavi Instagram
    • Gavi Facebook
    • Gavi YouTube
    • Gavi TikTok
    VSN logoCAF International logo

    Our achievements are thanks to the support and expertise of our founding partners

    • English
    • Français